Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022

Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, Caroline van den Ende, Noortje van Maarseveen, Lubna Ali, Boris Vlaemynck, Raf Schepers, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Chantal Reusken, Hester E. de Melker, Susan van den Hof, Mirjam J. Knol
doi: https://doi.org/10.1101/2022.02.06.22270457

Article usage

Article usage: February 2022 to November 2024

AbstractFullPdf
Feb 202276471311990
Mar 202295358235
Apr 202254032162
May 2022101640637
Jun 202251824179
Jul 202241152130
Aug 202246114106
Sep 2022381266
Oct 2022346541
Nov 2022293632
Dec 2022380214
Jan 2023319424
Feb 2023199512
Mar 2023209018
Apr 2023174341
May 2023182213
Jun 2023170113
Jul 2023141313
Aug 20231861229
Sep 20231931322
Oct 2023180317
Nov 20231741420
Dec 2023127616
Jan 2024130212
Feb 2024127425
Mar 2024146623
Apr 202485726
May 202468416
Jun 2024821018
Jul 202472421
Aug 2024691320
Sep 2024861222
Oct 20244729
Nov 202425012
Back to top
Posted February 08, 2022.
Download PDF
Data/Code
Email
Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022
Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, Caroline van den Ende, Noortje van Maarseveen, Lubna Ali, Boris Vlaemynck, Raf Schepers, RIVM COVID-19 surveillance and epidemiology team, Susan J.M. Hahné, Chantal Reusken, Hester E. de Melker, Susan van den Hof, Mirjam J. Knol
medRxiv 2022.02.06.22270457; doi: https://doi.org/10.1101/2022.02.06.22270457
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area